Literature DB >> 19839742

Evaluation of polyvinylpyrrolidone as a cryoprotectant for adipose tissue-derived adult stem cells.

Sreedhar Thirumala1, Xiying Wu, Jeffrey M Gimble, Ram V Devireddy.   

Abstract

The objective of this study was to test the hypothesis that human adipose tissue-derived adult stem cells (ASCs) can be effectively cryopreserved and stored in liquid nitrogen using a freezing medium containing a high-molecular-weight polymer, polyvinylpyrrolidone (PVP), as the cryoprotective agent (CPA) instead of dimethylsulfoxide (DMSO). To this end we investigated the postfreeze/thaw viability and apoptotic behavior of passage 1 ASCs cryopreserved in 15 different media: (i) the traditional media containing Dulbecco's modified Eagle's medium (DMEM) with 80% fetal calf serum (FCS) and 10% DMSO; (ii) DMEM with 80% human serum (HS) and 10% DMSO; (iii) DMEM with various concentrations (1%, 5%, 10%, 20%, and 40%) of PVP as the sole CPA; (iv) DMEM with PVP (5%, 10%, and 20%) and HS (10%); (v) DMEM with PVP (5%, 10%, and 20%) and FCS (10%); and (vi) DMEM with PVP (10%) and FCS (40% and 80%). Approximately 1 mL (10(6) cells/mL) of passage 1 ASCs were frozen overnight in a -80 degrees C freezer and stored in liquid nitrogen for 2 weeks before being rapidly thawed in a 37 degrees C water bath (1-2 min of agitation), resuspended in culture media, and seeded in separate wells of a six-well plate for a 24-h incubation period at 37 degrees C. After 24 h, the thawed samples were analyzed by bright-field microscopy and flow cytometry. The results suggest that the absence of DMSO significantly increases the fraction of apoptotic and/or necrotic ASCs. However, the percentage of viable cells obtained with 10% PVP and DMEM was comparable with that obtained in freezing media with DMSO and serum (HS or FCS), that is, approximately 70% + or - 8% and approximately 83% + or - 8%, respectively. Slightly enhanced cell viability was observed with the addition of serum (either HS or FCS) to the freezing media containing PVP as the CPA. Adipogenic and osteogenic differentiation behaviors of the frozen thawed cells were also assessed using histochemical staining and optical density measurements and the expression of adipogenic-associated genes was analyzed using reverse transcription-polymerase chain reaction. Our results suggest that after thawing, ASC viability and adipogenic and osteogenic differentiation abilities can be maintained even when ASCs are frozen in the absence of serum but with 10% PVP in DMEM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19839742     DOI: 10.1089/ten.TEC.2009.0552

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  19 in total

1.  Deleterious effects of freezing on osteogenic differentiation of human adipose-derived stromal cells in vitro and in vivo.

Authors:  Aaron W James; Benjamin Levi; Emily R Nelson; Michelle Peng; George W Commons; Min Lee; Benjamin Wu; Michael T Longaker
Journal:  Stem Cells Dev       Date:  2010-10-17       Impact factor: 3.272

Review 2.  Current methods of adipogenic differentiation of mesenchymal stem cells.

Authors:  Michelle A Scott; Virginia T Nguyen; Benjamin Levi; Aaron W James
Journal:  Stem Cells Dev       Date:  2011-06-20       Impact factor: 3.272

3.  Cryopreservation of Human Stem Cells for Clinical Application: A Review.

Authors:  Charles J Hunt
Journal:  Transfus Med Hemother       Date:  2011-03-16       Impact factor: 3.747

4.  Inducing Heat Shock Proteins Enhances the Stemness of Frozen-Thawed Adipose Tissue-Derived Stem Cells.

Authors:  Shahensha Shaik; Daniel Hayes; Jeffrey Gimble; Ram Devireddy
Journal:  Stem Cells Dev       Date:  2017-02-16       Impact factor: 3.272

Review 5.  Cryopreservation of Adipose-Derived Mesenchymal Stem Cells.

Authors:  Chika Miyagi-Shiohira; Kiyoto Kurima; Naoya Kobayashi; Issei Saitoh; Masami Watanabe; Yasufumi Noguchi; Masayuki Matsushita; Hirofumi Noguchi
Journal:  Cell Med       Date:  2015-08-26

Review 6.  Biomanufacturing for clinically advanced cell therapies.

Authors:  Ayesha Aijaz; Matthew Li; David Smith; Danika Khong; Courtney LeBlon; Owen S Fenton; Ronke M Olabisi; Steven Libutti; Jay Tischfield; Marcela V Maus; Robert Deans; Rita N Barcia; Daniel G Anderson; Jerome Ritz; Robert Preti; Biju Parekkadan
Journal:  Nat Biomed Eng       Date:  2018-06-11       Impact factor: 25.671

Review 7.  Preserving human cells for regenerative, reproductive, and transfusion medicine.

Authors:  Waseem Asghar; Rami El Assal; Hadi Shafiee; Raymond M Anchan; Utkan Demirci
Journal:  Biotechnol J       Date:  2014-07       Impact factor: 4.677

Review 8.  Manufacturing of primed mesenchymal stromal cells for therapy.

Authors:  James Q Yin; Jun Zhu; James A Ankrum
Journal:  Nat Biomed Eng       Date:  2019-01-28       Impact factor: 25.671

9.  Phenotypic and functional characterization of long-term cryopreserved human adipose-derived stem cells.

Authors:  Kar Wey Yong; Belinda Pingguan-Murphy; Feng Xu; Wan Abu Bakar Wan Abas; Jane Ru Choi; Siti Zawiah Omar; Mat Adenan Noor Azmi; Kien Hui Chua; Wan Kamarul Zaman Wan Safwani
Journal:  Sci Rep       Date:  2015-04-15       Impact factor: 4.379

10.  Bioprocessing of cryopreservation for large-scale banking of human pluripotent stem cells.

Authors:  Yan Li; Teng Ma
Journal:  Biores Open Access       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.